<div class="headers"><div>Table 1 Baseline characteristics of early DMARD-naive patients with RA participating in the SWEFOT trialPatients with available BMI for univariate analyses or with all data available for the multivariate model did not differ from the original SWEFOT trial population.
Proportions, n (%), were compared with Pearson’s χ2 , Continuous variables, medians (IQR), were compared with independent samples Mann-Whitney U tests. *All patients who originally participated in the SWEFOT. Missing data were as follows in number, n: BMI, 143; smoking status, 221; RF status, 4; anti-ACPA status, 25; concurrent prednisolone use, 3; HAQ, 6. †Univariate model, where the DAS28 at 24 months and baseline BMI were required. Missing data (n) were as follows: smoking status, 59; RF status, 1; ACPA status, 15; concurrent prednisolone use, 3; and HAQ, 4. ‡Multivariate model shown in table 2 and gure 3A. Missing data points (n) were as follows: RF status, 1; ACPA status, 7; concurrent prednisolone use, 2.
ACPA, anticitrullinated protein antibody; BMI, body mass index; DAS28, 28-joint count Disease Activity Score; DMARD, disease-modifying rheumatic drug; HAQ, Health Assessment Questionnaire; RA, rheumatoid arthritis; RF, rheumatoid factor; SWEFOT, Swedish Pharmacotherapy Trial.SWEFOT* (n=403)</div><div>Univariatet (n=215)</div><div>Multivariate^ (n=154)Proportions, n (%)Obese (BMI >30kg/m2)</div><div>43 (17)</div><div>39 (18)</div><div>26 (17)Overweight (BMI=25-29.9)</div><div>74 (28)</div><div>62 (29)</div><div>39 (25)Normal (BMI <25)</div><div>143 (55)</div><div>114 (53)</div><div>89 (58)Female sex</div><div>285 (71)</div><div>152 (71)</div><div>111 (72)Current smokers</div><div>41 (23)</div><div>34 (22)</div><div>34 (22)RF positive</div><div>274 (69)</div><div>141 (66)</div><div>95 (62)ACPA positive</div><div>237 (63)</div><div>127 (64)</div><div>92 (63)Concurrent prednisolone</div><div>58 (14)</div><div>28 (13)</div><div>19 (13)Medians (IQR)Age, years</div><div>56 (45-64)</div><div>56 (44-63)</div><div>56 (44-63)Symptom duration, months</div><div>5 (4-8)</div><div>6 (4-8)</div><div>6 (4-9)DAS28</div><div>5.7 (4.9-6.3)</div><div>5.9 (5.1-6.5)</div><div>5.9 (5.2-6.6)HAQ score</div><div>1.1 (0.8-1.5)</div><div>1.3 (0.9-1.8)</div><div>1.2 (0.8-1.8)</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<tbody>
<tr style='border-top: 2px solid grey;'>
<td style='border-top: 2px solid grey; text-align: left;'><p style="font-weight: bold; " class="firstCol bold ">Table 1 Baseline characteristics of early DMARD-naive patients with RA participating in the SWEFOT trial</p></td>
<td style='border-top: 2px solid grey; text-align: left;'></td>
<td style='border-top: 2px solid grey; text-align: left;'></td>
<td style='border-top: 2px solid grey; text-align: left;'></td>
</tr>
<tr>
<td style='text-align: left;'><p style="font-weight: bold; " class="firstCol bold ">Patients with available BMI for univariate analyses or with all data available for the multivariate model did not differ from the original SWEFOT trial population.
Proportions, n (%), were compared with Pearson’s χ2 , Continuous variables, medians (IQR), were compared with independent samples Mann-Whitney U tests. *All patients who originally participated in the SWEFOT. Missing data were as follows in number, n: BMI, 143; smoking status, 221; RF status, 4; anti-ACPA status, 25; concurrent prednisolone use, 3; HAQ, 6. †Univariate model, where the DAS28 at 24 months and baseline BMI were required. Missing data (n) were as follows: smoking status, 59; RF status, 1; ACPA status, 15; concurrent prednisolone use, 3; and HAQ, 4. ‡Multivariate model shown in table 2 and gure 3A. Missing data points (n) were as follows: RF status, 1; ACPA status, 7; concurrent prednisolone use, 2.
ACPA, anticitrullinated protein antibody; BMI, body mass index; DAS28, 28-joint count Disease Activity Score; DMARD, disease-modifying rheumatic drug; HAQ, Health Assessment Questionnaire; RA, rheumatoid arthritis; RF, rheumatoid factor; SWEFOT, Swedish Pharmacotherapy Trial.</p></td>
<td style='text-align: left;'></td>
<td style='text-align: left;'></td>
<td style='text-align: left;'></td>
</tr>
<tr>
<td style='text-align: left;'></td>
<td style='text-align: left;'><p style="font-weight: bold; " class="bold ">SWEFOT* (n=403)</p></td>
<td style='text-align: left;'><p style="font-weight: bold; " class="bold ">Univariatet (n=215)</p></td>
<td style='text-align: left;'><p style="font-weight: bold; " class="bold ">Multivariate^ (n=154)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="font-style: italic; " class="firstCol italic ">Proportions, n (%)</p></td>
<td style='text-align: left;'></td>
<td style='text-align: left;'></td>
<td style='text-align: left;'></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Obese (BMI >30kg/m2)</p></td>
<td style='text-align: left;'><p style="" class="">43 (17)</p></td>
<td style='text-align: left;'><p style="" class="">39 (18)</p></td>
<td style='text-align: left;'><p style="" class="">26 (17)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Overweight (BMI=25-29.9)</p></td>
<td style='text-align: left;'><p style="" class="">74 (28)</p></td>
<td style='text-align: left;'><p style="" class="">62 (29)</p></td>
<td style='text-align: left;'><p style="" class="">39 (25)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Normal (BMI <25)</p></td>
<td style='text-align: left;'><p style="" class="">143 (55)</p></td>
<td style='text-align: left;'><p style="" class="">114 (53)</p></td>
<td style='text-align: left;'><p style="" class="">89 (58)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Female sex</p></td>
<td style='text-align: left;'><p style="" class="">285 (71)</p></td>
<td style='text-align: left;'><p style="" class="">152 (71)</p></td>
<td style='text-align: left;'><p style="" class="">111 (72)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Current smokers</p></td>
<td style='text-align: left;'><p style="" class="">41 (23)</p></td>
<td style='text-align: left;'><p style="" class="">34 (22)</p></td>
<td style='text-align: left;'><p style="" class="">34 (22)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">RF positive</p></td>
<td style='text-align: left;'><p style="" class="">274 (69)</p></td>
<td style='text-align: left;'><p style="" class="">141 (66)</p></td>
<td style='text-align: left;'><p style="" class="">95 (62)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">ACPA positive</p></td>
<td style='text-align: left;'><p style="" class="">237 (63)</p></td>
<td style='text-align: left;'><p style="" class="">127 (64)</p></td>
<td style='text-align: left;'><p style="" class="">92 (63)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Concurrent prednisolone</p></td>
<td style='text-align: left;'><p style="" class="">58 (14)</p></td>
<td style='text-align: left;'><p style="" class="">28 (13)</p></td>
<td style='text-align: left;'><p style="" class="">19 (13)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="font-style: italic; " class="firstCol italic ">Medians (IQR)</p></td>
<td style='text-align: left;'></td>
<td style='text-align: left;'></td>
<td style='text-align: left;'></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Age, years</p></td>
<td style='text-align: left;'><p style="" class="">56 (45-64)</p></td>
<td style='text-align: left;'><p style="" class="">56 (44-63)</p></td>
<td style='text-align: left;'><p style="" class="">56 (44-63)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Symptom duration, months</p></td>
<td style='text-align: left;'><p style="" class="">5 (4-8)</p></td>
<td style='text-align: left;'><p style="" class="">6 (4-8)</p></td>
<td style='text-align: left;'><p style="" class="">6 (4-9)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">DAS28</p></td>
<td style='text-align: left;'><p style="" class="">5.7 (4.9-6.3)</p></td>
<td style='text-align: left;'><p style="" class="">5.9 (5.1-6.5)</p></td>
<td style='text-align: left;'><p style="" class="">5.9 (5.2-6.6)</p></td>
</tr>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'><p style="" class="">HAQ score</p></td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p style="" class="">1.1 (0.8-1.5)</p></td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p style="" class="">1.3 (0.9-1.8)</p></td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p style="" class="">1.2 (0.8-1.8)</p></td>
</tr>
</tbody>
</table>
